Founded in Charlottesville, United States, SoundPipe is a medical device startup dedicated to revolutionizing drug delivery through the use of ultrasound technology. Their core mission is to enhance the safety and efficacy of drug delivery for the treatment of critical limb ischemia (CLI). The company's flagship product, Penello, is an intravascular drug delivery platform that utilizes an ultrasound catheter to precisely deliver antiproliferative drugs to arteries post-angioplasty, aiming to prevent restenosis.
SoundPipe's innovative approach has garnered attention from notable figures in the medical and investment communities. The company holds patents for its groundbreaking technology, positioning it as a leader in the field of ultrasound-mediated drug delivery. Key achievements include successful development phases and promising preclinical results, which have the potential to significantly impact the treatment of CLI and other vascular diseases. SoundPipe's advancements promise to improve patient outcomes and set new standards in medical interventions.